Ziyan Shi,Xiaofei Wang,Jiancheng Wang,Hongxi Chen,Qin Du,Yanlin Lang,Lingyao Kong,Wenqin Luo,Yuhan Qiu,Ying Zhang,Chen Li,Dingke Wen,Jie Yao,Xia Cheng,Linjun Cai,Xue Lin,Rui Wang,Zichao Mou,Shuangjie Li,Duanya Liu,Hong Zhou,Hongyu Zhou,Mu Yang

Abstract:Multiple sclerosis (MS) leads to demyelination and neurodegeneration with autoimmune responses in central nervous system. Patients begin with a relapsing–remitting (RR) course, and more than 80% of them may advance to secondary progressive MS (SPMS), which is characteristic for the gradual decline of neurological functions without demonstrated treating method to prevent. This study aims to investigate the contribution of peripheral CD8 + T cells during the conversion from RRMS to SPMS, as well as reveal potential diagnostic signature in distinguishing SPMS.

Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression